Reports for AMGEN CANADA INC
Company Name
AMGEN CANADA INC
Totals |
||
Shortage reports |
3 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 3 (100%) | |
Discontinuation Reports |
4 |
|
To be discontinued: | 1 (25%) | |
Discontinued: | 3 (75%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SENSIPAR | 30MG | TABLET | Resolved | 2024-06-11 | 2024-09-18 | 230090 |
SENSIPAR | 60MG | TABLET | Resolved | 2024-06-11 | 2024-09-18 | 230105 |
SENSIPAR | 90MG | TABLET | Resolved | 2024-06-11 | 2024-09-18 | 230112 |
Showing 1 to 3 of 3
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
REPATHA | 120MG | SOLUTION | To be discontinued | 2024-03-26 | 2024-07-18 | 223420 |
SENSIPAR | 30MG | TABLET | Discontinued | 2024-09-18 | 2024-09-18 | 237894 |
SENSIPAR | 60MG | TABLET | Discontinued | 2024-09-18 | 2024-09-18 | 237897 |
SENSIPAR | 90MG | TABLET | Discontinued | 2024-09-18 | 2024-09-18 | 237900 |
Showing 1 to 4 of 4